Goldman Jonathan sold AVTX

November 14, 2025 · Form 4 insider transaction

Goldman Jonathan sold 3,167 shares of Avalo Therapeutics, Inc. at $14.30 per share, a transaction worth $45.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.